MYC's Fine Line Between B Cell Development and Malignancy
- PMID: 32102485
- PMCID: PMC7072781
- DOI: 10.3390/cells9020523
MYC's Fine Line Between B Cell Development and Malignancy
Abstract
The transcription factor MYC is transiently expressed during B lymphocyte development, and its correct modulation is essential in defined developmental transitions. Although temporary downregulation of MYC is essential at specific points, basal levels of expression are maintained, and its protein levels are not completely silenced until the B cell becomes fully differentiated into a plasma cell or a memory B cell. MYC has been described as a proto-oncogene that is closely involved in many cancers, including leukemia and lymphoma. Aberrant expression of MYC protein in these hematological malignancies results in an uncontrolled rate of proliferation and, thereby, a blockade of the differentiation process. MYC is not activated by mutations in the coding sequence, and, as reviewed here, its overexpression in leukemia and lymphoma is mainly caused by gene amplification, chromosomal translocations, and aberrant regulation of its transcription. This review provides a thorough overview of the role of MYC in the developmental steps of B cells, and of how it performs its essential function in an oncogenic context, highlighting the importance of appropriate MYC regulation circuitry.
Keywords: B cell development; MYC; leukemia; lymphoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.Cell Death Dis. 2015 Feb 12;6(2):e1635. doi: 10.1038/cddis.2014.594. Cell Death Dis. 2015. PMID: 25675295 Free PMC article.
-
STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.Oncogene. 2013 Nov 7;32(45):5283-91. doi: 10.1038/onc.2012.543. Epub 2012 Nov 26. Oncogene. 2013. PMID: 23178486 Free PMC article.
-
The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers.Nat Immunol. 2012 Nov;13(11):1092-100. doi: 10.1038/ni.2418. Epub 2012 Sep 23. Nat Immunol. 2012. PMID: 23001146 Free PMC article.
-
ETS1 Function in Leukemia and Lymphoma.Adv Exp Med Biol. 2024;1459:359-378. doi: 10.1007/978-3-031-62731-6_16. Adv Exp Med Biol. 2024. PMID: 39017852 Review.
-
MYC, Metabolism, and Cancer.Cancer Discov. 2015 Oct;5(10):1024-39. doi: 10.1158/2159-8290.CD-15-0507. Epub 2015 Sep 17. Cancer Discov. 2015. PMID: 26382145 Free PMC article. Review.
Cited by
-
Beyond Telomeres: Unveiling the Extratelomeric Functions of TERT in B-Cell Malignancies.Cancers (Basel). 2025 Mar 30;17(7):1165. doi: 10.3390/cancers17071165. Cancers (Basel). 2025. PMID: 40227701 Free PMC article. Review.
-
Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma.Yonago Acta Med. 2023 Jan 25;66(1):56-66. doi: 10.33160/yam.2023.02.007. eCollection 2023 Feb. Yonago Acta Med. 2023. PMID: 36820285 Free PMC article.
-
IL-4 alters TLR7-induced B cell developmental program in lupus.Clin Immunol. 2025 Jun;275:110472. doi: 10.1016/j.clim.2025.110472. Epub 2025 Mar 9. Clin Immunol. 2025. PMID: 40068727
-
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.EMBO Mol Med. 2021 Oct 7;13(10):e13598. doi: 10.15252/emmm.202013598. Epub 2021 Aug 30. EMBO Mol Med. 2021. PMID: 34459560 Free PMC article.
-
Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications.J Appl Genet. 2024 Feb;65(1):57-72. doi: 10.1007/s13353-023-00804-5. Epub 2023 Nov 25. J Appl Genet. 2024. PMID: 38001281 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical